AD109

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study That Tests AD109 in Patients Taking GLP-1 DrugsNCT06400615ApnimedPhase 2Completed2024-12-26Actual
Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)NCT05813275ApnimedPhase 3Completed2025-03-10Actual
Parallel Arm Trial of AD109 and AD504 In Patients With OSANCT05071612ApnimedPhase 2Completed2022-07-20Actual
Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)NCT05811247ApnimedPhase 3Completed2025-05-07Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.